M3 Reports Progress on Ongoing ¥20 Billion Share Buyback Program

M3 ( (JP:2413) ) has provided an update.

M3, Inc. has reported the status of its ongoing share repurchase program authorized by its board in May 2025 under the Companies Act of Japan. Between January 1 and January 31, 2026, the company bought back 206,200 common shares on the Tokyo Stock Exchange through discretionary trading, for a total of ¥418.7 million, bringing cumulative repurchases under the current authorization to 1,966,700 shares at a cost of about ¥4.07 billion. The program allows for purchases of up to 20 million shares or ¥20 billion through April 30, 2026, giving M3 continued flexibility to return capital to shareholders and potentially support its share price, although the company notes that actual repurchases may fall short of the stated maximum depending on market conditions.

The most recent analyst rating on (JP:2413) stock is a Hold with a Yen2092.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.

More about M3

M3, Inc., listed on the Tokyo Stock Exchange Prime Market, operates in the healthcare and medical information services sector, providing online platforms and related solutions that connect medical professionals, pharmaceutical companies, and healthcare stakeholders in Japan and globally.

YTD Price Performance: -9.63%

Average Trading Volume: 3,784,408

Technical Sentiment Signal: Sell

Current Market Cap: Yen1297.4B

See more insights into 2413 stock on TipRanks’ Stock Analysis page.